Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Immunotherapy

  • Open Access
    New Approaches in Targeted Therapy for Medulloblastoma in Children
    HENRIETTA MAIER, TINA DALIANIS and OURANIA N. KOSTOPOULOU
    Anticancer Research April 2021, 41 (4) 1715-1726; DOI: https://doi.org/10.21873/anticanres.14936
  • You have access
    Impact of Renin–angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients
    TAKEHIRO TOZUKA, NORIKO YANAGITANI, HIROSHI YOSHIDA, RYO MANABE, SHINSUKE OGUSU, RYOSUKE TSUGITOMI, HIROAKI SAKAMOTO, YOSHIAKI AMINO, RYO ARIYASU, KEN UCHIBORI, SATORU KITAZONO, MASAHIRO SEIKE, AKIHIKO GEMMA and MAKOTO NISHIO
    Anticancer Research April 2021, 41 (4) 2093-2100; DOI: https://doi.org/10.21873/anticanres.14980
  • You have access
    Predictive Impact of Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy
    YUDAI ISHIYAMA, TSUNENORI KONDO, YUKI NEMOTO, YUKI KOBARI, HIROKI ISHIHARA, HIDEKAZU TACHIBANA, KAZUHIKO YOSHIDA, YASUNOBU HASHIMOTO, TOSHIO TAKAGI, JUNPEI IIZUKA and KAZUNARI TANABE
    Anticancer Research March 2021, 41 (3) 1607-1614; DOI: https://doi.org/10.21873/anticanres.14922
  • You have access
    Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer
    MAX R. CLEVERS, ELISABETH A. KASTELIJN, BAS J.M. PETERS, HANS KELDER and FRANZ M.N.H. SCHRAMEL
    Anticancer Research February 2021, 41 (2) 869-876; DOI: https://doi.org/10.21873/anticanres.14839
  • You have access
    Lower Genital Tract Melanomas: Staging, Predictors of Outcome, and New Therapeutic Options
    EVA KATHARINA EGGER, MATTHIAS B. STOPE, FLORIAN RECKER, DOMINIQUE KONSGEN, JENNIFER LANDSBERG, ANNE FROHLICH, ALINA ABRAMIAN and ALEXANDER MUSTEA
    Anticancer Research February 2021, 41 (2) 999-1004; DOI: https://doi.org/10.21873/anticanres.14854
  • You have access
    Chemoradiotherapy in Cancer Treatment: Rationale and Clinical Applications
    KATHRINE S. RALLIS, THOMAS HO LAI YAU and MICHAIL SIDERIS
    Anticancer Research January 2021, 41 (1) 1-7; DOI: https://doi.org/10.21873/anticanres.14746
  • You have access
    Role of LLT1 and PCNA as Natural Killer Cell Immune Evasion Strategies of HCT 116 Cells
    JOSEPH D. MALAER and PORUNELLOOR A. MATHEW
    Anticancer Research December 2020, 40 (12) 6613-6621; DOI: https://doi.org/10.21873/anticanres.14686
  • You have access
    Differential Analyses of Peripheral Blood Parameters in CCR5 Inhibition-treated Colorectal Cancer Patients Reveal Dynamic Changes Linked to Clinical Outcomes
    AZAZ AHMED and NIELS HALAMA
    Anticancer Research December 2020, 40 (12) 6933-6939; DOI: https://doi.org/10.21873/anticanres.14717
  • You have access
    Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial
    KOICHI MITSUYA, YASUTO AKIYAMA, AKIRA IIZUKA, HARUO MIYATA, SHOICHI DEGUCHI, NAKAMASA HAYASHI, CHIE MAEDA, RYOTA KONDOU, AKARI KANEMATSU, KYOKO WATANABE, TADASHI ASHIZAWA, YOSHIAKI ABE, ICHIRO ITO, TAKUMA OISHI, TAKASHI SUGINO, YOKO NAKASU and KEN YAMAGUCHI
    Anticancer Research November 2020, 40 (11) 6473-6484; DOI: https://doi.org/10.21873/anticanres.14669
  • You have access
    The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents
    Y. MAURICE MORILLON, ARIANA SABZEVARI, JEFFREY SCHLOM and JOHN W. GREINER
    Anticancer Research October 2020, 40 (10) 5329-5341; DOI: https://doi.org/10.21873/anticanres.14540

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire